Zhenlin Ju
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Advanced Biosensing Techniques and Applications 10
- Gene expression and cancer classification 9
- Molecular Biology Techniques and Applications 7
- PI3K/AKT/mTOR signaling in cancer 6
- Oncology 20
- PARP inhibition in cancer therapy 8
- Co-authors
- Gordon B. Mills (39 shared papers)Guang Peng (5 shared papers)Yiling Lu (23 shared papers)Yang Peng (3 shared papers)Jianfeng Shen (3 shared papers)Timothy A. Yap (5 shared papers)Wei Zhao (3 shared papers)Lulu Wang (2 shared papers)
- Journals
- Cancer Research (8 papers)Clinical Cancer Research (4 papers)British Journal of Cancer (3 papers)Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (3 papers)Nature Communications (2 papers)
- Partner nations
- United StatesChinaIreland
In The Last Decade
Zhenlin Ju
69 papers receiving 3.6k citations
Zhenlin Ju's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.3k
- Reproductive Medicine 380
- Cancer Research 599
- Molecular Biology 2.3k
- Immunology 672
Countries citing papers authored by Zhenlin Ju
This map shows the geographic impact of Zhenlin Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlin Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlin Ju more than expected).
Fields of papers citing papers by Zhenlin Ju
This network shows the impact of papers produced by Zhenlin Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlin Ju. The network helps show where Zhenlin Ju may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenlin Ju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness Hit paper breakdown → | 2018 | 427 |
| 2 | ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors Hit paper breakdown → | 2015 | 358 |
| 3 | 2011 | 352 | |
| 4 | 2018 | 205 | |
| 5 | 2017 | 170 | |
| 6 | 2009 | 159 | |
| 7 | 2002 | 97 | |
| 8 | 2020 | 87 | |
| 9 | 2006 | 85 | |
| 10 | 2000 | 84 | |
| 11 | 2002 | 79 | |
| 12 | 2010 | 71 | |
| 13 | 2014 | 71 | |
| 14 | 2006 | 68 | |
| 15 | 2014 | 65 | |
| 16 | 2018 | 63 | |
| 17 | 2019 | 59 | |
| 18 | 2008 | 57 | |
| 19 | 2000 | 55 | |
| 20 | 2001 | 55 |
About Zhenlin Ju
Zhenlin Ju is a scholar working on Molecular Biology, Oncology, Cancer Research, Spectroscopy and Pathology and Forensic Medicine, having authored 73 papers that have together received 3.7k indexed citations. Recurring topics across this work include Advanced Biosensing Techniques and Applications (10 papers), Advanced Proteomics Techniques and Applications (9 papers), Gene expression and cancer classification (9 papers), PARP inhibition in cancer therapy (8 papers), Ovarian cancer diagnosis and treatment (8 papers), Cancer Genomics and Diagnostics (7 papers), Molecular Biology Techniques and Applications (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Oncology (1.3k citations), Reproductive Medicine (380 citations), Cancer Research (599 citations), Molecular Biology (2.3k citations) and Immunology (672 citations). Zhenlin Ju has collaborated with scholars based in United States, China and Ireland. Frequent co-authors include Gordon B. Mills, Guang Peng, Yiling Lu, Yang Peng, Jianfeng Shen, Timothy A. Yap, Wei Zhao, Lulu Wang, Ronald B. Walter and Bryan T. Hennessy. Their work appears in journals such as Cancer Research, Clinical Cancer Research, British Journal of Cancer, Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.